Wiedermann C J, Niedermühlbichler M, Zilian U, Geissler D, Lindley I, Braunsteiner H
Department of Internal Medicine, Faculty of Medicine, University of Innsbruck, Austria.
Regul Pept. 1991 Nov 26;36(3):359-68. doi: 10.1016/0167-0115(91)90069-s.
Tachykinins have priming effects on polymorphonuclear neutrophils, since they may activate the neutrophils to exhibit an exaggerated inflammatory response to phlogistic mediators. In order to investigate mechanisms involved in this action, we determined the influence of substance P and neurokinin A on chemotaxis of human neutrophils towards gradients of formymethionyl-leucyl-phenylalanine or recombinant human interleukin-8. As seen with other neutrophil-priming agents such as tumor necrosis factor-alpha, exposure of neutrophils to substance P or neurokinin A had an inhibitory effect upon a stimulated migration, with effective concentrations being in the nanomolar range. Tuftsin, a known neutrophil activating peptide, similarly inhibited stimulated migration. Analysis of structure-activity relationships revealed that activity of tachykinins is located in amino-terminal, tuftsin-like sequences. The inhibition of stimulated migration was partly reversed by (Pro1)-tuftsin, a partial tuftsin receptor antagonist, which suggests that the effects of amino-terminal tachykinins involves activation of tuftsin receptors of neutrophils.
速激肽对多形核中性粒细胞有启动作用,因为它们可能激活中性粒细胞,使其对炎症介质表现出过度的炎症反应。为了研究这一作用所涉及的机制,我们测定了P物质和神经激肽A对人中性粒细胞向甲酰甲硫氨酰-亮氨酰-苯丙氨酸梯度或重组人白细胞介素-8趋化性的影响。正如其他中性粒细胞启动剂如肿瘤坏死因子-α所显示的那样,将中性粒细胞暴露于P物质或神经激肽A对刺激迁移有抑制作用,有效浓度在纳摩尔范围内。已知的中性粒细胞激活肽促吞噬素同样抑制刺激迁移。结构-活性关系分析表明,速激肽的活性位于氨基末端的促吞噬素样序列中。促吞噬素(Pro1)(一种部分促吞噬素受体拮抗剂)可部分逆转刺激迁移的抑制作用,这表明氨基末端速激肽的作用涉及中性粒细胞促吞噬素受体的激活。